SGLT2 inhibitors in type 2 diabetes: Recommendations within updated NICE guideline NG28 | GPnotebook TV

This site is intended for UK healthcare professionals

GPnotebook ↗︎
GPnotebook Podcast ↗︎
blank
×

SGLT2 inhibitors in type 2 diabetes: Recommendations within updated NICE guideline NG28

14 February 2022
Dr Anish Kotecha explores the recommendations on sodium–glucose cotransporter 2 (SGLT2) inhibitors within updated guidance on type 2 diabetes management in adults from NICE.

Categories

Tags

blank

The content of this website is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. Any distribution or duplication of the information contained herein is strictly prohibited.

© Oxbridge Solutions Ltd, 2023

 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.